Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 4:42 AM
Ignite Modification Date: 2025-12-25 @ 4:42 AM
NCT ID: NCT01152918
Eligibility Criteria: Inclusion/Exclusion Criteria for Linkage-to-Care Component: The Linkage-to-Care component of the study will include all individuals ages 12 and older who are permitted to consent, or can be consented for HIV care by a parent/legal guardian according to New York State or Washington, D.C. law, and who are newly found to be HIV-positive at HIV test sites participating in the study. This study component will also include individuals who have been previously diagnosed with HIV but have been out of care for at least a year and are reconfirmed for HIV infection by standard laboratory tests Inclusion/Exclusion Criteria for Viral Suppression Component: The study population for the viral suppression component of the study will include all individuals ages 12 and older who are permitted to consent, or can be consented for HIV care by a parent/legal guardian according to New York State or Washington, D.C. law, who have initiated care at participating HIV care sites. Inclusion Criteria for Prevention for Positives Component: * All people who are permitted to consent for HIV care according to New York State or Washington, D.C. law * Receiving care at the selected HIV care sites in the Bronx or Washington, D.C. * Have attended the clinic one or more times in the 7 months before study entry * Able to understand either spoken English or Spanish * Able and willing to provide informed consent * Participants enrolled into the Prevention for Positives component of the study will participate in the Patient Survey Component Exclusion Criteria for Prevention for Positives Component: * Not seen in the clinic in the 7 months before study entry * History or evidence of altered mentation, inebriation, or substance use that would interfere with participation in the study * Unable or unwilling to provide informed consent * Participation in another study focusing on HIV prevention for positives
Healthy Volunteers: False
Sex: ALL
Study: NCT01152918
Study Brief:
Protocol Section: NCT01152918